• Product NameDeferasirox
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityDeferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.
• Target NameOthers
• CAS No. 201530-41-8
• Calculated MW 373.36
• Formulation C21H15N3O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism system
  SMILES:C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1
  Pathways:Others
  Receptor:iron
  Boling pt:651C?
  Melting pt:260-262C
  Solubility:Ethanol: 2 mg/mL (5.35 mM); DMSO: 74 mg/mL (198.2 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Wang T, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1359-64.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting